Israel Englander’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Israel Englander’s Portfolio TCRR Stock Details TCRR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,000	Closed	-$255K	–	7605
2021 Q3	$255K	Buy	+30,000	New	+$424K	﹤0.01%	5934

Israel Englander's TCRR Position: Q2 2023 in Review

Israel Englander sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q2 2023, closing a stake of 31,683 shares — an estimated $48K sold.

Israel Englander first reported a position in TCRR in Q1 2019 and held it in 16 quarters. The position peaked at $15M in Q4 2020. 0 funds tracked by Wall St. Rank hold TCRR as of Q2 2023.

Israel Englander reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Israel Englander sold 31,683 TCR2 Therapeutics Inc. Common Stock shares in Q2 2023, an estimated $48K.
Israel Englander first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2019 and held it in 16 quarters.
Israel Englander's TCR2 Therapeutics Inc. Common Stock position peaked at $15M in Q4 2020.
0 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.